Peption LLC developed a new technology to produce custom synthetic antibodies. Our synthetic antibodies are designed to interact specifically with the custom epitope sequence (8-12 amino acids) of the target protein. This new technology will provide innovative solutions for many biotechnological applications including disease prevention, diagnostics, and therapeutics.